BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18087171)

  • 1. rHuEPO dose inversely correlated with the number of circulating CD34+ cells in maintenance hemodialysis patients.
    Kohagura K; Ohya Y; Miyagi S; Ishida A; Yakabi S; Iseki K; Yamane N; Takishita S
    Nephron Clin Pract; 2008; 108(1):c41-6. PubMed ID: 18087171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating endothelial progenitor cells are reduced in hemodialysis patients.
    Eizawa T; Murakami Y; Matsui K; Takahashi M; Muroi K; Amemiya M; Takano R; Kusano E; Shimada K; Ikeda U
    Curr Med Res Opin; 2003; 19(7):627-33. PubMed ID: 14606986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants.
    Meister B; Maurer H; Simma B; Kern H; Ulmer H; Hittmair A; Fink FM
    Stem Cells; 1997; 15(5):359-63. PubMed ID: 9323798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History of cardiovascular disease is associated with endothelial progenitor cells in peritoneal dialysis patients.
    Steiner S; Schaller G; Puttinger H; Födinger M; Kopp CW; Seidinger D; Grisar J; Hörl WH; Minar E; Vychytil A; Wolzt M; Sunder-Plassmann G
    Am J Kidney Dis; 2005 Sep; 46(3):520-8. PubMed ID: 16129215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of protein-energy malnutrition on erythropoietin requirement in maintenance hemodialysis patients.
    Akgul A; Bilgic A; Sezer S; Ozdemir FN; Olcay I; Arat Z; Haberal M
    Hemodial Int; 2007 Apr; 11(2):198-203. PubMed ID: 17403171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between erythropoietin requirements and antihypertensive agents.
    Yano S; Suzuki K; Iwamoto M; Urushidani Y; Yokogi H; Kusakari M; Aoki A; Sumi M; Kitamura K; Sanematsu H; Gohbara M; Imamura S; Sugimoto T
    Nephron Clin Pract; 2008; 109(1):c33-9. PubMed ID: 18506108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of immutable variables determining rHuEPO dose requirements on hemodialysis patients].
    Gascón A; Virto R; Lou LM; Pernaute R; Moreno R; Pérez J; Aladrén MJ; Moragrega B; Castillón E; Gómez R; Vives PJ; Alvarez R; García FJ; Castilla J; Gutiérrez Colón JA
    Nefrologia; 2005; 25(5):535-42. PubMed ID: 16392304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perturbation of autocrine/paracrine loops of burst-forming units of erythroid-derived cells in rHuEPO-hyporesponsive hemodialysis patients.
    Nakao K; Wada J; Ota K; Ichikawa H; Akagi S; Okamoto A; Hida K; Nagake Y; Makino H
    Am J Kidney Dis; 2003 Mar; 41(3):624-36. PubMed ID: 12612986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysis modality is independently associated with circulating endothelial progenitor cells in end-stage renal disease patients.
    Ueno H; Koyama H; Fukumoto S; Tanaka S; Shoji T; Shoji T; Emoto M; Tahara H; Tsujimoto Y; Tabata T; Nishizawa Y
    Nephrol Dial Transplant; 2010 Feb; 25(2):581-6. PubMed ID: 19628645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors.
    Deschaseaux F; Selmani Z; Falcoz PE; Mersin N; Meneveau N; Penfornis A; Kleinclauss C; Chocron S; Etievent JP; Tiberghien P; Kantelip JP; Davani S
    Eur J Pharmacol; 2007 May; 562(1-2):111-8. PubMed ID: 17320859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise capacity and circulating endothelial progenitor cells in hemodialysis patients.
    Manfredini F; Rigolin GM; Malagoni AM; Soffritti S; Boari B; Conconi F; Castoldi GL; Catizone L; Zamboni P; Manfredini R
    Int J Sports Med; 2007 May; 28(5):368-73. PubMed ID: 17024634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients.
    Kato A; Tsuji T; Luo J; Sakao Y; Yasuda H; Hishida A
    Am J Nephrol; 2008; 28(1):115-21. PubMed ID: 17943020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors contributing to higher hematocrit levels in hemodialysis patients not receiving recombinant human erythropoietin.
    Takeda A; Toda T; Shinohara S; Mogi Y; Matsui N
    Am J Kidney Dis; 2002 Jul; 40(1):104-9. PubMed ID: 12087567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders.
    Passamonti F; Vanelli L; Malabarba L; Rumi E; Pungolino E; Malcovati L; Pascutto C; Morra E; Lazzarino M; Cazzola M
    Haematologica; 2003 Oct; 88(10):1123-9. PubMed ID: 14555308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial damage and repair in antineutrophil cytoplasmic antibody-associated vasculitis.
    de Groot K; Goldberg C; Bahlmann FH; Woywodt A; Haller H; Fliser D; Haubitz M
    Arthritis Rheum; 2007 Nov; 56(11):3847-53. PubMed ID: 17968939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis.
    Buemi M; Costa C; Floccari F; Coppolino G; Campo S; Bolignano D; Sturiale A; Lacquaniti A; Buemi A; Loddo S; Teti D
    J Nephrol; 2010; 23(3):328-34. PubMed ID: 20301080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients.
    Pirro M; Schillaci G; Menecali C; Bagaglia F; Paltriccia R; Vaudo G; Mannarino MR; Mannarino E
    J Hypertens; 2007 Oct; 25(10):2093-9. PubMed ID: 17885552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of poor responders to erythropoietin among children undergoing hemodialysis.
    Seeherunvong W; Rubio L; Abitbol CL; Montané B; Strauss J; Diaz R; Zilleruelo G
    J Pediatr; 2001 May; 138(5):710-4. PubMed ID: 11343048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased circulating CD34+ cells are associated with progression of diabetic nephropathy.
    Makino H; Okada S; Nagumo A; Sugisawa T; Miyamoto Y; Kishimoto I; Kikuchi-Taura A; Soma T; Taguchi A; Yoshimasa Y
    Diabet Med; 2009 Feb; 26(2):171-3. PubMed ID: 19236621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.